Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Inks $20M Credit Facility with GE Healthcare

NEW YORK (GenomeWeb News) – Helicos Biosciences will use a $20 million senior secured credit facility from GE Healthcare Financial Services to shore up its working capital and to fund commercialization efforts, the company said today.
 
The company received an initial $10 million under the facility on Dec. 31, and it will be able to draw down the remaining $10 million through the end of June. The first $10 million will be amortized over 36 months, and Helicos will owe interest-only payments over the initial 12 months.
 
Helicos, which went public in May 2007, said in its November earnings report that it was surviving on minimal revenue from grants while it amped up its R&D spending and took a $10 million net loss for the third quarter.
 
Helicos CEO Steve Lombardi said in a statement that the loan will allow the company to “scale up our manufacturing and build inventory to meet customer demand in 2008 and beyond.”
 
The firm expects to soon launch its HeliScope next-generation sequencing instrument.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.